Angiogenesis and Vascular Repair in Acute Kidney Injury

Authors

  • Athira U Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, INDIA.
  • Sonia Sonia Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, INDIA.
  • Astha Sharma Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, INDIA.
  • Sachit Sharma Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, INDIA.

DOI:

https://doi.org/10.55544/jrasb.4.2.6

Keywords:

Acute kidney injury, angiogenesis, vascular repair, endothelial dysfunction, vascular endothelial growth factor

Abstract

Chronic kidney disease (CKD) is one of the most dangerous medical illnesses that can be caused by acute kidney injury (AKI), which is characterised by the sudden cessation of normal kidney function. This condition can also lead to other major complications. Abnormalities of the endothelium, inflammation, and oxidative stress are all factors that contribute to the development of acute kidney injury (AKI), which primarily impacts the vasculature of the kidneys. Renal regeneration is dependent on angiogenesis and vascular repair pathways, which include hypoxia-inducible pathways, vascular endothelial growth factor signalling, and the activation of endothelial progenitor cells. These pathways are essential for the regeneration of the human kidney. Angiogenesis that is not properly regulated can, unfortunately, hasten the onset of chronic kidney disease (CKD), which can then result in maladaptive repair and fibrosis. In acute kidney injury (AKI), there is an immediate need for novel therapeutic approaches that focus on the molecular mechanisms of vascular repair in order to enhance regeneration while simultaneously reducing pathological remodelling. The purpose of this study is to discuss the function of angiogenesis and vascular repair in acute kidney injury (AKI), as well as to highlight potential treatment methods that could improve renal outcomes.

Downloads

Download data is not yet available.

References

Huang J, Chen J, Yang J, Han M, Xue Z, Wang Y, Xu M, Qi H, Wang Y. Prediction models for acute kidney injury following liver transplantation: A systematic review and critical appraisal. Intensive and Critical Care Nursing. 2025 Feb 1;86:103808.

Sarker MS. Rhabdomyolysis-related acute kidney injury in COVID-19: A critical concern. World Journal of Virology. 2025 Mar 25;14(1).

Alvitigala BY, Gooneratne LV, Gnanathasan CA, Wijewickrama ES. Snakebite-associated acute kidney injury in South Asia: narrative review on epidemiology, pathogenesis and management. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2025 Jan 3:trae077.

Bellomo R, Kellum JA, Ronco C. Acute kidney injury. The Lancet. 2012 Aug 25;380(9843):756-66.

Ronco C, Bellomo R, Kellum JA. Acute kidney injury. The Lancet. 2019 Nov 23;394(10212):1949-64.

Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ. Acute kidney injury. Nature reviews Disease primers. 2021 Jul 15;7(1):52.

Zuk A, Bonventre JV. Acute kidney injury. Annual review of medicine. 2016 Jan 14;67(1):293-307.

Kellum JA. Acute kidney injury. Critical care medicine. 2008 Apr 1;36(4):S141-5.

Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Comprehensive Physiology. 2012 Apr;2(2):1303.

Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA, Liu KD, Mehta RL, Pannu N, Van Biesen W, Vanholder R. Acute kidney injury: an increasing global concern. The Lancet. 2013 Jul 13;382(9887):170-9.

Thomas ME, Blaine C, Dawnay A, Devonald MA, Ftouh S, Laing C, Latchem S, Lewington A, Milford DV, Ostermann M. The definition of acute kidney injury and its use in practice. Kidney international. 2015 Jan 1;87(1):62-73.

Pérez-Aizpurua X, Benavente RC, Serrano GB, Peral JM, Mañas BG, i Jaumot JT, de Castroviejo Blanco JR, Ospina FO, Gonzalez-Enguita C. Obstructive uropathy: Overview of the pathogenesis, etiology and management of a prevalent cause of acute kidney injury. World journal of nephrology. 2024 Jun 25;13(2):93322.

Li C, Yu Y, Zhu S, Hu Y, Ling X, Xu L, Zhang H, Guo K. The emerging role of regulated cell death in ischemia and reperfusion-induced acute kidney injury: current evidence and future perspectives. Cell death discovery. 2024 May 4;10(1):216.

Chen Y, Li Z, Zhang H, Chen H, Hao J, Liu H, Li X. Mitochondrial metabolism and targeted treatment strategies in ischemic-induced acute kidney injury. Cell Death Discovery. 2024 Feb 10;10(1):69.

Chirico V, Lacquaniti A, Tripodi F, Conti G, Marseglia L, Monardo P, Gitto E, Chimenz R. Acute kidney injury in neonatal intensive care unit: epidemiology, diagnosis and risk factors. Journal of Clinical Medicine. 2024 Jun 13;13(12):3446.

Muhammad N, Liaqat N. Causes and outcome of pregnancy related acute kidney injury. Pakistan Journal of Medical Sciences. 2024 Jan;40(1Part-I):64.

Iba T, Helms J, Maier CL, Levi M, Scarlatescu E, Levy JH. The role of thromboinflammation in acute kidney injury among patients with septic coagulopathy. Journal of Thrombosis and Haemostasis. 2024 Feb 19.

Cai D, Chen Q, Mao L, Xiao T, Wang Y, Gu Q, Wang Q, Ji Y, Sun L. Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients. European Journal of Clinical Pharmacology. 2024 Apr;80(4):613-20.

Li Y, Wang J. Contrast-induced acute kidney injury: a review of definition, pathogenesis, risk factors, prevention and treatment. BMC nephrology. 2024 Apr 22;25(1):140.

Waziri B, Umar IA, Magaji A, Umelo CC, Nalado AM, Wester CW, Aliyu MH. Risk factors and outcomes associated with pregnancy-related acute kidney injury in a high-risk cohort of women in Nigeria. Journal of nephrology. 2024 Apr;37(3):587-96.

Chen JJ, Lee TH, Kuo G, Yen CL, Lee CC, Chang CH, Tu KH, Chen YC, Fang JT, Hung CC, Yang CW. All-cause and immune checkpoint inhibitor–associated acute kidney injury in immune checkpoint inhibitor users: a meta-analysis of occurrence rate, risk factors and mortality. Clinical Kidney Journal. 2024 Jan;17(1):sfad292.

Jalal SJ, Al-Mukhtar SE, Amin KH. Incidence and risk factors for acute kidney injury in intensive care unit patients, a single center study in Sulaimaniyah. Risk. 2024;3:4.

Golestaneh L, Basalely A, Linkermann A, El-Achkar TM, Kim RS, Neugarten J. Sex, Acute Kidney Injury, and Age: A Prospective Cohort Study. American Journal of Kidney Diseases. 2025 Mar 1;85(3):329-38.

Jeppesen KK, Rasmussen SB, Kjaergaard J, Schmidt H, Mølstrøm S, Beske RP, Grand J, Ravn HB, Winther-Jensen M, Meyer MA, Hassager C. Acute kidney injury after out-of-hospital cardiac arrest. Critical Care. 2024 May 18;28(1):169.

Li L, Ding L, Zheng L, Wu L, Hu Z, Liu L, Yao Y. Relationship between stress hyperglycemia ratio and acute kidney injury in patients with congestive heart failure. Cardiovascular Diabetology. 2024 Jan 13;23(1):29.

WANG X, FENG Z, WANG J, GUO X, LI J. Risk Factors for Acute Kidney Injury in Acute Respiratory Distress Syndrome: a Systematic Review. Chinese General Practice. 2025 Apr 20;28(12):1527.

Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney international. 2007 Jul 2;72(2):151-6.

Iba T, Helms J, Maier CL, Levi M, Scarlatescu E, Levy JH. The role of thromboinflammation in acute kidney injury among patients with septic coagulopathy. Journal of Thrombosis and Haemostasis. 2024 Feb 19.

Song Z, Xia Y, Shi L, Zha H, Huang J, Xiang X, Li H, Huang H, Yue R, Wang H, Zhu J. Inhibition of Drp1-Fis1 interaction alleviates aberrant mitochondrial fragmentation and acute kidney injury. Cellular & Molecular Biology Letters. 2024 Mar 4;29(1):31.

Zhang C, Zhang Y, Liu D, Mei M, Song N, Zhuang Q, Jiang Y, Guo Y, Liu G, Li X, Ren L. Dexmedetomidine mitigates acute kidney injury after coronary artery bypass grafting: a prospective clinical trial. Revista Española de Cardiología (English Edition). 2024 Aug 1;77(8):645-55.

Zlatanovic P, Davidovic L, Mascia D, Ancetti S, Yeung KK, Jongkind V, Viitala H, Venermo M, Wiersema A, Chiesa R, Gargiulo M. Acute kidney injury in patients undergoing endovascular or open repair of juxtarenal or pararenal aortic aneurysms. Journal of Vascular Surgery. 2024 Jun 1;79(6):1347-59.

Mansour SG, Zhang WR, Moledina DG, Coca SG, Jia Y, Thiessen-Philbrook H, McArthur E, Inoue K, Koyner JL, Shlipak MG, Wilson FP. The association of angiogenesis markers with acute kidney injury and mortality after cardiac surgery. American Journal of Kidney Diseases. 2019 Jul 1;74(1):36-46.

Tanaka T, Nangaku M. Angiogenesis and hypoxia in the kidney. Nature Reviews Nephrology. 2013 Apr;9(4):211-22.

Devarajan P. Update on mechanisms of ischemic acute kidney injury. Journal of the American Society of Nephrology. 2006 Jun 1;17(6):1503-20.

Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nature Reviews Nephrology. 2011 Apr;7(4):189-200.

Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney international. 2007 Jul 2;72(2):151-6.

Tanabe K, Wada J, Sato Y. Targeting angiogenesis and lymphangiogenesis in kidney disease. Nature Reviews Nephrology. 2020 May;16(5):289-303.

Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Comprehensive Physiology. 2012 Apr;2(2):1303.

Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. The Journal of clinical investigation. 2011 Nov 1;121(11):4210-21.

Basile DP, Collett JA, Yoder MC. Endothelial colony‐forming cells and pro‐angiogenic cells: clarifying definitions and their potential role in mitigating acute kidney injury. Acta physiologica. 2018 Feb;222(2):e12914.

Tanaka S, Tanaka T, Nangaku M. Hypoxia and dysregulated angiogenesis in kidney disease. Kidney diseases. 2015 May 1;1(1):80-9.

Nilsson M, Heymach JV. Vascular endothelial growth factor (VEGF) pathway. Journal of Thoracic Oncology. 2006 Oct 1;1(8):768-70.

Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. Journal of clinical oncology. 2005 Feb 10;23(5):1011-27.

Shibuya M. Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E. Endothelium. 2006 Jan 1;13(2):63-9.

Giles FJ. The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignancies. The oncologist. 2001 Oct 1;6(S5):32-9.

Kowanetz M, Ferrara N. Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clinical Cancer Research. 2006 Sep 1;12(17):5018-22.

Duffy AM, Bouchier-Hayes DJ, Harmey JH. Vascular endothelial growth factor (VEGF) and its role in non-endothelial cells: autocrine signalling by VEGF. InMadame Curie Bioscience Database [Internet] 2013. Landes Bioscience.

Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clinical science. 2005 Sep 1;109(3):227-41.

Ciardiello F, Troiani T, Bianco R, Orditura M, Morgillo F, Martinelli E, Morelli MP, Cascone T, Tortora G. Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy. Annals of Oncology. 2006 Jun 1;17:vii109-14.

Andringa KK, Agarwal A. Role of hypoxia-inducible factors in acute kidney injury. Nephron Clinical Practice. 2014 Sep 1;127(1-4):70-4.

Shu S, Wang Y, Zheng M, Liu Z, Cai J, Tang C, Dong Z. Hypoxia and hypoxia-inducible factors in kidney injury and repair. Cells. 2019 Feb 28;8(3):207.

Xu ZH, Wang C, He YX, Mao XY, Zhang MZ, Hou YP, Li B. Hypoxia-inducible factor protects against acute kidney injury via the Wnt/β-catenin signaling pathway. American Journal of Physiology-Renal Physiology. 2022 Jun 1;322(6):F611-24.

Nangaku M, Rosenberger C, Heyman SN, Eckardt KU. Regulation of hypoxia‐inducible factor in kidney disease. Clinical and Experimental Pharmacology and Physiology. 2013 Feb;40(2):148-57.

Haase VH. Hypoxia-inducible factors in the kidney. American Journal of Physiology-Renal Physiology. 2006 Aug;291(2):F271-81.

Li ZL, Ji JL, Wen Y, Cao JY, Kharbuja N, Ni WJ, Yin D, Feng ST, Liu H, Lv LL, Liu BC. HIF-1α is transcriptionally regulated by NF-κB in acute kidney injury. American Journal of Physiology-Renal Physiology. 2021 Aug 6.

Weidemann A, Bernhardt WM, Klanke B, Daniel C, Buchholz B, Ca V, Amann K, Warnecke C, Wiesener MS, Eckardt KU, Willam C. HIF activation protects from acute kidney injury. Journal of the American Society of Nephrology. 2008 Mar 1;19(3):486-94.

Nangaku M, Inagi R, Miyata T, Fujita T. Hypoxia and hypoxia-inducible factor in renal disease. Nephron Experimental Nephrology. 2008 Sep 1;110(1):e1-7.

He FF, Zhang D, Chen Q, Zhao Y, Wu L, Li ZQ, Zhang C, Jiang ZH, Wang YM. Angiopoietin‐Tie signaling in kidney diseases: an updated review. FEBS letters. 2019 Oct;593(19):2706-15.

Li Y, Liu P, Zhou Y, Maekawa H, Silva JB, Ansari MJ, Boubes K, Alia Y, Deb DK, Thomson BR, Jin J. Activation of angiopoietin-tie2 signaling protects the kidney from ischemic injury by modulation of endothelial-specific pathways. Journal of the American Society of Nephrology. 2023 Jun 1;34(6):969-87.

Parikh SM. The angiopoietin-Tie2 signaling axis in systemic inflammation. Journal of the American Society of Nephrology. 2017 Jul 1;28(7):1973-82.

Saharinen P, Eklund L, Alitalo K. Therapeutic targeting of the angiopoietin–TIE pathway. Nature Reviews Drug Discovery. 2017 Sep;16(9):635-61.

Sack KD, Kellum JA, Parikh SM. The angiopoietin-Tie2 pathway in critical illness. Critical care clinics. 2020 Jan 31;36(2):201.

Kim W. The role of angiopoietin-1 in kidney disease. Electrolytes & Blood Pressure: E & BP. 2008 Jun 1;6(1):22-6.

Luo AJ, Chang FC, Lin SL. Exploring Angiopoietin-2: Clinical Insights and Experimental Perspectives in Kidney Diseases. Kidney International Reports. 2024 Sep 6.

YUAN HT, SURI C, YANCOPOULOS GD, WOOLF AS. Expression of angiopoietin-1, angiopoietin-2, and the Tie-2 receptor tyrosine kinase during mouse kidney maturation. Journal of the American Society of Nephrology. 1999 Aug 1;10(8):1722-36.

Aslan A, Jongman RM, Moser J, Stegeman CA, van Goor H, Diepstra A, van den Heuvel MC, Heeringa P, Molema G, Zijlstra JG, van Meurs M. The renal angiopoietin/Tie2 system in lethal human sepsis. Critical Care. 2014 Apr;18:1-3.

Patschan D, Patschan S, Müller GA. Endothelial progenitor cells in acute ischemic kidney injury: strategies for increasing the cells′ renoprotective competence. International Journal of Nephrology. 2011;2011(1):828369.

Veith AP, Henderson K, Spencer A, Sligar AD, Baker AB. Therapeutic strategies for enhancing angiogenesis in wound healing. Advanced drug delivery reviews. 2019 Jun 1;146:97-125.

Deveza L, Choi J, Yang F. Therapeutic angiogenesis for treating cardiovascular diseases. Theranostics. 2012 Aug 16;2(8):801.

Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011 May 19;473(7347):298-307.

Pandya NM, Dhalla NS, Santani DD. Angiogenesis—a new target for future therapy. Vascular pharmacology. 2006 May 1;44(5):265-74.

Barui AK, Nethi SK, Haque S, Basuthakur P, Patra CR. Recent development of metal nanoparticles for angiogenesis study and their therapeutic applications. ACS Applied Bio Materials. 2019 Oct 18;2(12):5492-511.

Liekens S, De Clercq E, Neyts J. Angiogenesis: regulators and clinical applications. Biochemical pharmacology. 2001 Feb 1;61(3):253-70.

Yoo SY, Kwon SM. Angiogenesis and its therapeutic opportunities. Mediators of inflammation. 2013;2013(1):127170.

Makarevich PI, Parfyonova YV. Therapeutic angiogenesis: foundations and practical application. Physiologic and Pathologic Angiogenesis—Signaling Mechanisms and Targeted Therapy; Simionescu, D., Simionescu, A., Eds. 2017 Apr 5:343-64.

Simons M, Ware JA. Therapeutic angiogenesis in cardiovascular disease. Nature reviews Drug discovery. 2003 Nov 1;2(11):863-72.

Fan TP, Jagger R, Bicknell R. Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends in pharmacological sciences. 1995 Feb 1;16(2):57-66.

Downloads

Published

2025-04-13

How to Cite

Athira , U., Sonia, S., Sharma, A., & Sharma, S. (2025). Angiogenesis and Vascular Repair in Acute Kidney Injury. Journal for Research in Applied Sciences and Biotechnology, 4(2), 38–47. https://doi.org/10.55544/jrasb.4.2.6

Issue

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.